Clinical and Microbiologic Characteristics of Cephalosporin-Resistant Escherichia coli at Three Centers in the United States

Susceptibility of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae According to the New CLSI Breakpoints

(2011) Peng Wang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Identification of CTX-M β-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities

(2010) Carl Urban et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals

(2010) Gisele Peirano et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania

(2009) H. E. Sidjabat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Features and Molecular Epidemiology of CMY‐Type β‐Lactamase–ProducingEscherichia coli

(2009) Hanna E. Sidjabat et al.   CLINICAL INFECTIOUS DISEASES

AmpC  -Lactamases

(2009) G. A. Jacoby   CLINICAL MICROBIOLOGY REVIEWS

Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing blaKPC in the United States

(2008) A. Endimiani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-spectrum β-lactamases in North America, 1987–2006

(2008) K. Bush   CLINICAL MICROBIOLOGY AND INFECTION

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES